Validation of prevalent diabetes risk scores based on non-invasively measured predictors in Ghanaian migrant and non-migrant populations – The RODAM study
James Osei-Yeboah(Kwame Nkrumah University of Science and Technology), Charles Agyemang(Johns Hopkins University), Liam Smeeth(London School of Hygiene & Tropical Medicine), Erik Beune(University of Amsterdam), Eric P. Moll van Charante(Amsterdam Neuroscience), Matthias B. Schulze(Brigham and Women's Hospital), Silver Bahendeka(Nsambya Hospital), Karlijn Meeks(University of Amsterdam), Kerstin Klipstein‐Grobusch(University Medical Center Utrecht), Ellis Owusu‐Dabo(Kwame Nkrumah University of Science and Technology), André Pascal Kengne(South African Medical Research Council)
Cited by 2
Related Papers
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
|BMJ|2024|2.8k
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
|The Lancet|2016|2.7k
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults
|The Lancet|2024|2.2k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k